OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
AKR1C1 overexpression leads to lenvatinib resistance in hepatocellular carcinoma
Cheng Gao, Liang Chang, Tianxin Xu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1412-1433
Open Access | Times Cited: 8
Cheng Gao, Liang Chang, Tianxin Xu, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 3, pp. 1412-1433
Open Access | Times Cited: 8
Showing 8 citing articles:
New Opportunities in the Systemic Treatment of Hepatocellular Carcinoma—Today and Tomorrow
Rafał Becht, Kajetan Kiełbowski, Michał Wasilewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1456-1456
Open Access | Times Cited: 10
Rafał Becht, Kajetan Kiełbowski, Michał Wasilewicz
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1456-1456
Open Access | Times Cited: 10
IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via STAT3/CD155 signaling axis
Junzhang Chen, Shiran Sun, Hui Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Junzhang Chen, Shiran Sun, Hui Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 7
Lenvatinib radiofrequency ablation sequential therapy offers survival benefits for patients with unresectable hepatocellular carcinoma at intermediate stage and the liver reserve of Child–Pugh A category: A multicenter study
Ying Zhang, Kazushi Numata, Kento Imajo, et al.
Hepatology Research (2024) Vol. 54, Iss. 12, pp. 1174-1192
Closed Access
Ying Zhang, Kazushi Numata, Kento Imajo, et al.
Hepatology Research (2024) Vol. 54, Iss. 12, pp. 1174-1192
Closed Access
Tilte：SNRPA may mediate transcription and splicing of genesassociated with HCC via binding special RNAs
Qingyao Chang, Yidi Wang, Jun Xu
Research Square (Research Square) (2024)
Open Access
Qingyao Chang, Yidi Wang, Jun Xu
Research Square (Research Square) (2024)
Open Access
Roles of clinical application of lenvatinib and its resistance mechanism in advanced hepatocellular carcinoma (Review)
Ganghui Ye, Meng Ye, Xin Jin
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4113-4171
Closed Access
Ganghui Ye, Meng Ye, Xin Jin
American Journal of Cancer Research (2024) Vol. 14, Iss. 9, pp. 4113-4171
Closed Access
Integrating T-cell inflammation features for prognosis in hepatocellular carcinoma: a novel predictive model
Peng Tang, Tianlun Wang, Fei Song, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 6, pp. 2613-2629
Open Access
Peng Tang, Tianlun Wang, Fei Song, et al.
Journal of Gastrointestinal Oncology (2024) Vol. 15, Iss. 6, pp. 2613-2629
Open Access
ACTB may serve as a predictive marker for the efficacy of lenvatinib in patients with HBV-related early-stage hepatocellular carcinoma following partial hepatectomy: a retrospective cohort study
Wei Dong, Minghao Zou, Jie Sheng, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 6, pp. 2479-2499
Open Access
Wei Dong, Minghao Zou, Jie Sheng, et al.
Journal of Gastrointestinal Oncology (2023) Vol. 14, Iss. 6, pp. 2479-2499
Open Access
